This Article Full Text Full Text (PDF) All Versions of this Article: 40/5/1842    most recent STROKEAHA.108.538686v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Liu, F. Articles by McCullough, L. D. Search for Related Content PubMed PubMed Citation Articles by Liu, F. Articles by McCullough, L. D. Related Collections Animal models of human disease Apoptosis Acute Cerebral Infarction

(Stroke. 2009;40:1842.)
© 2009 American Heart Association, Inc.

Original Contributions

Sex Differences in Caspase Activation After Stroke

Fudong Liu, MD; Zhong Li, MD, PhD; Jun Li, PhD; Chad Siegel, PhD; Rongwen Yuan, MD, PhD Louise D. McCullough, MD, PhD

From Department of Neurology and Neuroscience (F.L., Z.L., J.L., C.S., R.Y., L.D.M.), University of Connecticut Health Center, Farmington, Conn; Department of Neurology (F.L.), Yijishan Hospital, Wuhu, Anhui, China.

Correspondence to Louise D. McCullough, MC-1840, Department of Neurology, 263 Farmington Avenue, Farmington, CT 06030. E-mail lmccullough{at}uchc.edu

Background and Purpose— Over the past 5 years, experimental data have emerged that ischemia-induced cell death pathways may differ in males and females. Cell death in males is triggered by poly(ADP-ribose) polymerase activation and nuclear translocation of apoptosis-inducing factor. We have previously shown that interference with this pathway benefits males but not females after an experimental stroke. In contrast, caspase activation may be the major pathway activated after ischemic injury in females. The aim of this study is to examine whether sex differences exist in caspase activation in adult mice after stroke and to determine if interference with stroke-induced caspase activation preferentially protects females.

Methods— Focal stroke was induced by reversible middle cerebral artery occlusion (90 minutes) in young and aging C57BL/6 mice of both sexes. The pan-caspase inhibitor, quinoline-Val-Asp(Ome)-CH2-O-phenoxy was administered at reperfusion. Histological outcomes were assessed 48 hours after middle cerebral artery occlusion. Separate cohorts were used for protein analysis of key cell death proteins, including caspase-3, caspase-8, cytochrome C, and apoptosis-inducing factor.

Results— Drug-treated female mice had significantly decreased infarct volumes and improved neurological deficits after stroke compared to vehicle-treated mice. Quinoline-Val-Asp(Ome)-CH2-O-phenoxy administration had no effect in male mice. The expression of cytochrome C and nuclear caspase-8 levels were increased in females after stroke.

Conclusions— Female mice had an early release of cytochrome C and enhanced caspase activation after middle cerebral artery occlusion. Caspase inhibition benefited females but not males. Sex differences exist in both the response to ischemic injury and the efficacy of neuroprotective agents.

Key Words: caspase • cytochrome C • middle cerebral artery occlusion • sex differences • stroke